Archit Organosys Ltd

Archit Organosys Annual Report

Archit Organosys Limited issued a corrigendum to its FY 2025-26 Annual Report, withdrawing Agenda Items 8, 9, and 10 from the upcoming AGM notice.

Archit Organosys Annual General Meeting

Archit Organosys has withdrawn three agenda items from the upcoming AGM, including an authorised capital increase, an acquisition, and a proposed preferential issue for restructuring.

Archit Organosys Annual General Meeting

Archit Organosys Limited announced its 33rd Annual General Meeting to be held on 30th September 2026. The board recommended a dividend of Re. 1 per share.

Archit Organosys Annual Report

Archit Organosys Ltd has filed its Annual Report for the financial year 2025-26. The submission includes audited financial statements and director's reports for the period.

Archit Organosys Dividend

Archit Organosys has fixed September 23, 2026, as the record date to determine shareholder eligibility for the final dividend recommended for FY 2025-26.

Archit Organosys Capital Structure Change

Archit Organosys will issue 3.72 crore shares via preferential allotment at ₹65/share, totaling ₹242.11 Crore, to acquire a stake in Archit Life Science Limited.

Value

₹242.1 Cr

Archit Organosys Q1 FY27 Results: Net Profit ₹1.4 Cr, Down 30.0% YoY

Archit Organosys Ltd reported revenue from operations of ₹37.1 Cr (+11.7% YoY) and net profit of ₹1.4 Cr (-30.0% YoY) for Q1 FY27.

Key figure

Net profit ₹1.4 Cr · -30.0% YoY

Archit Organosys Q4 FY26 Results: Net Profit ₹2 Cr, Up 0.0% YoY

Archit Organosys Ltd reported revenue from operations of ₹36.5 Cr (-15.5% YoY) and net profit of ₹2 Cr (+0.0% YoY) for Q4 FY26.

Key figure

Net profit ₹2 Cr · +0.0% YoY